RhCE模型在医疗器械眼刺激评价中的应用潜力与挑战Progress and Challenges in the Application of RhCE Models for Eye Irritation Evaluation of Medical Devices
何弦,卢昕,陈献花,许珂佳
摘要(Abstract):
眼刺激评价是眼科医疗器械生物相容性评价的重要环节。随着实验动物“3R”原则的推进,3D重组人角膜上皮(reconstructed human cornea-like epithelium,RhCE)模型已成为替代传统Draize兔眼试验的研究热点。该文分析了传统动物试验的局限性,系统综述了RhCE模型的构建原理、生物学特性、主流商用模型应用现状,以及MTT组织活力、跨上皮电阻和炎症因子释放等评价指标的应用。此外,探讨了RhCE模型在医疗器械监管中的采信现状、面临的挑战与发展前景,为我国医疗器械生物学评价的体外替代方法建设提供参考。
关键词(KeyWords): RhCE模型;医疗器械;眼刺激;体外替代方法;生物学评价
基金项目(Foundation): 浙江省药品监管科技计划项目(2026029);; 浙江省基础公益研究计划(LGD22C040004)
作者(Author): 何弦,卢昕,陈献花,许珂佳
参考文献(References):
- [1]ISO 10993-23:2021 Biological evaluation of medical devices — part 23:tests for irritation[S].
- [2]GB/T 16886.23—2023 医疗器械生物学评价 第23部分:刺激试验[S].
- [3]OECD. Test No. 405:acute eye irritation/corrosion[R/OL]. 2023-07-04. https://doi.org/10.1787/9789264185333-en.
- [4]Kolle S N,Haase P,Wareing B,et al. Not yet nixing rabbit eyes from the six:the TTT is not predicting the full range of in vivo eye irritation classifications for agrochemical formulations[J]. Regul Toxicol Pharmacol,2025,161:105841.
- [5]Kandárová H, P??bi?? P. The “ big three” in biocompatibility testing of medical devices:implementation of alternatives to animal experimentation-are we there yet[J].Front Toxicol,2023,5:1337468.
- [6]Caloni F, De Angelis I, Hartung T. Replacement of animal testing by integrated approaches to testing and assessment ( IATA): a call for in vivo trosi[J]. Arch Toxicol,2022,96(7):1935-1950.
- [7]Loiseau A, Ra??che-Marcoux G, Maranda C, et al.Animal models in eye research: focus on corneal pathologies[J]. Int J Mol Sci,2023,24(23):16661.
- [8]Lieto K,Skopek R,Lewicka A,et al. Looking into the eyes-in vitro models for ocular research[J]. Int J Mol Sci,2022,23(16):9158.
- [9]García-Posadas L,Diebold Y. Three-dimensional human cell culture models to study the pathophysiology of the anterior eye[J]. Pharmaceutics,2020,12(12):1215.
- [10]Borodianskiy-Shteinberg T, Bisht P, Das B, et al.Commercial human 3D corneal epithelial equivalents for modeling epithelial infection in herpes keratitis[J]. Virology,2024,595:110096.
- [11]OECD. Test No. 492:reconstructed human cornealike epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage[R/OL]. 2025-06-25. https://doi.org/10.1787/9789264242548-en.
- [12]Choudhary S,Parveen N,Javed M,et al. Alternative models for evaluation of ocular toxicological effects of environmental chemicals and pharmaceuticals: a review[J]. Cutan Ocul Toxicol,2026,45(1):74-96.
- [13]P??bi?? P, Milasová T, Kandárová H. Exploring the potential of reconstructed human epithelial tissue models for safety assessment of intraoral medical devices[J]. Toxicol In Vitro,2025,104:105956.
- [14]Chacón M,Vázquez N,Berisa S,et al. QobuR-a new in vitro human corneal epithelial model for preclinical drug screening[J]. Eur J Pharm Biopharm,2019,136:164-173.
- [15]Lotz C,Kiesewetter L,Schmid F F,et al. Replacing the draize eye test: impedance spectroscopy as a 3R method to discriminate between all GHS categories for eye irritation[J]. Sci Rep,2018,8(1):15049.
- [16]van der Zalm A J, Daniel A B, Raabe H A, et al.Defined approaches to classify agrochemical formulations into EPA hazard categories developed using EpiOcular TM reconstructed human corneal epithelium and bovine corneal opacity and permeability assays[J]. Cutan Ocul Toxicol,2024,43(1):58-68.
- [17]Chacón M,Vázquez N,Persinal-Medina M,et al. Inhouse performance assessment of 3D QobuR-reconstructed human cornea-like epithelium (RhCE)for the evaluation of eye hazard[J]. Toxicol In Vitro,2022,82:105390.
- [18]Kim Y J,Seo D H,Kim I S,et al. Preliminary study on an alternative test method with MCTT HCETM for ocular irritation test of ophthalmic medical devices[J]. Toxics,2023,11(3):289.
- [19]Hikima T, Ezaki H. Predicting the safety of ocular iontophoresis using reconstructed human corneal epithelial cells[J]. Biol Pharm Bull, 2023, 46(7):1021-1023.
- [20]Knetzger N, Ertych N, Burgdorf T, et al. Noninvasive in vitro NAM for the detection of reversible and irreversible eye damage after chemical exposure for GHS classification purposes (ImAi)[J]. Arch Toxicol,2025,99(3):1011-1028.
- [21]Kim S H,Jo S H,Kim B K,et al. Tissue engineered mini-cornea model for eye irritation test[J]. Tissue Eng Regen Med,2023,20(2):213-223.
- [22]Hu Nianfang, Cheng Kerun, Zhang Shuhan, et al.Advancements in microfluidics for skin cosmetic screening[J]. Analyst,2023,148(8):1653-1671.
- [23]Barrios-Esteban S, Alcalde I, Chacón M, et al.Protamine nanocapsules as gene delivery carriers for the treatment of intraocular tumors[J]. Drug Deliv Transl Res,2026,16(6):1754-1772.
- [24]Zhong Cheng, Wanasathop A, Shi Zhanquan, et al.Evaluation of in vitro cornea models for quantifying destructive effects of chemicals[J]. Toxicol In Vitro,2022,85:105462.
- [25]Nie Xiongfeng,Wang Leying,Xu Ziyang,et al. 3Dbioprinted biomimetic epithelial-stromal hydrogel construct with in situ photocrosslinkable bioadhesive for suture-free corneal regeneration[J]. Adv Healthc Mater,2025,15(12):e04578.
- [26]Trujillo S. Evolution of ocular organ-on-chip systems for disease modelling and drug testing: where are we now[J]. Adv Ther,2025,8(9):e00200.
- [27]Zamudio Díaz D F, Hülse P, Schleusener J, et al.Corneal safety assessment of germicidal far UV-C radiation[J]. Sci Rep,2025,15(1):24052.
- [28]Lee T,Kyung S Y,Kwon M,et al. Innovations in skin microphysiological systems for nonclinical testing and FDA modernization[J]. Microsyst Nanoeng, 2026,12(1):44.
- [29]Weissinger H,Knetzger N,Cleve C,et al. Impedancebased in vitro eye irritation testing enables the categorization of diluted chemicals[J]. Sci Rep, 2024,14(1):6216.
- [30]Abo T,Deguchi Y,Yuki T,et al. Evaluation of MTT reducers and strongly colored substances in the short time exposure test method for assessing eye irritation potential[J]. J Toxicol Sci,2023,48(6):363-374.
- [31]Yozgatl1 V,??stünda??Okur N, Okur M E, et al.Managing allergic conjunctivitis via ophthalmic microemulsions: formulation, characterization, in vitro irritation studies based on EpiOcular TM eye irritation assay and in vivo studies in rabbit eye[J]. J Surfactants Deterg,2023,26(6):853-866.
- [32]Chauchat L,Guerin C,Kaluzhny Y,et al. Comparison of in vitro corneal permeation and in vivo ocular bioavailability in rabbits of three marketed latanoprost formulations[J]. Eur J Drug Metab Pharmacokinet,2023,48(6):633-645.
- [33]Belser J A,Pulit-Penaloza J A,Brock N,et al. Ocular infectivity and replication of a clade 2.3. 4.4b a(H5N1) influenza virus associated with human conjunctivitis in a dairy farm worker in the USA:an in-vitro and ferret study[J]. Lancet Microbe, 2025,6(7):101070.
- [34]Silva A M,Garcia J,Dall’Acqua S,et al. Eco-friendly insights on kiwiberry leaves valorization through in-vitro and in-vivo studies[J]. Ind Crops Prod, 2022, 184:115090.
- [35]Kaluzhny Y, Klausner M. In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development[J]. In Vitro Cell Dev Biol Anim,2021,57(2):207-237.
- [36]Morofuji R, Enomoto H, Honda T, et al. Exploring cell-penetrating peptides as penetration enhancers in eye drop formulations using a reconstructed human corneal epithelial model[J]. Biol Pharm Bull, 2023,46(12):1720-1730.
- [37]Kojima H. History of the organisation for economic cooperation and development (OECD) test guidelines for non-animal test methods in Japan[J]. Genes Environ,2025,47(1):3.
- [38]何立成,孙叶丹,朱社敏,等. 基于BioOcullar??模型的清洁类化妆品眼刺激性评价方法的建立[J]. 日用化学工业,2022,52(5):529-533.
- [39]Nikodinoska I,Spohr C,Dillon G P,et al. Skin and eye irritancy assessment of six lactic acid bacteria strains[J]. Regul Toxicol Pharmacol, 2023, 141:105406.
- [40]He Xian,Fang Li,Chen Xianhua,et al. Application of a 3D human cornea-like epithelium for eye irritation assessment of contact lens solutions[J]. J Appl Toxicol,2025,45(10):1984-1994.
- [41]Rauchman S H, Locke B, Albert J, et al. Toxic external exposure leading to ocular surface injury[J]. Vision (Basel),2023,7(2):32.
- [42]Yun J-W, Hailian Q, Na Y, et al. Exploration and comparison of in vitro eye irritation tests with the ISO standard in vivo rabbit test for the evaluation of the ocular irritancy of contact lenses[J]. Toxicol In Vitro, 2016,37:79-87.
- [43]P??bi??P,KubalcováJ,MilasováT,et al. Development of sensitive in vitro protocols for the biocompatibility testing of medical devices and pharmaceuticals intended for contact with the eyes: acute irritation and phototoxicity assessment[J/OL]. Altern Lab Anim,2024,52(5):261-275.
- [44]Meloni M, Balzaretti S, Ceriotti L. Medical devices biocompatibility assessment on HCE: evidences of delayed cytotoxicity of preserved compared to preservative free eye drops[J]. Regul Toxicol Pharmacol,2019,106:81-89.
- [45]Yamamoto N, Hiramatsu N, Kato Y, et al.Development of an eye irritation test method using an inhouse fabrication of a reconstructed human cornea-like epithelium model for eye hazard identification[J]. Bioengineering,2024,11(4):302.
- [46]Alcalde I,Sánchez-Fernández C,Azpeitia??,et al. In vitro model of reconstructed human corneal epithelium for the evaluation of ocular surface desiccation and protection with vitamin A enriched ophthalmic ointment[J]. J Pharm Sci, 2025, 114(2): 1108-1116.
- [47]Sokolowski K,Turner P V,Lewis E,et al. Exploring rabbit as a nonrodent species for general toxicology studies[J]. Toxicol Sci,2024,199(1):29-39.
- [48]Cimino C, Vidal L B, Conti F, et al. From preformulative design to in vivo tests:a complex path of requisites and studies for nanoparticle ocular application. part 2: in vitro, ex vivo, and in vivo studies[J]. Mol Pharm,2024,21(12):6062-6099.
- [49]Vanin J, Getz M, Mahony C, et al. V-cornea: a computational model of corneal epithelium homeostasis, injury, and recovery[J]. PLoS Comput Biol,2025,21(12):e1013410.
- [50]Lenze M, Benedetti M D, Roco J, et al. Advancing ocular safety research:a comprehensive examination of benzocaine acute exposure without animal testing[J]. Toxicol Lett,2024,394:138-145.